Scientists from UCLA report that women who experience extreme morning sickness during pregnancy are three times more likely to have children with developmental issues, including attention disorders and language and speech delays, than woman who have normal nausea and vomiting. This is the first research to look specifically at in utero exposure to extreme morning sickness, or Hyperemesis Gravidarum (HG), and childhood neurologic developmental outcomes, said Marlena Fejzo, Ph.D., who added that this was especially true in women whose HG symptoms began very early, prior to five weeks gestation.
“These findings show that it is vital to take HG seriously so these pregnant women can get nutritional support right away,” pointed out Dr. Fejzo, an associate researcher in the David Geffen School of Medicine at UCLA. “An encouraging finding is that we did not find any association with medications to treat this disorder and neurodevelopmental delays, so I speculate that the neurodevelopmental outcomes are more likely caused by nutrient deficiency early in pregnancy rather than medication.”
The UCLA team’s study (“Neurodevelopmental delay in children exposed in utero to hyperemesis gravidarum”) appears in the early online edition of the European Journal of Obstetrics and Gynecology and Reproductive Biology.
HG is the condition that Duchess Kate Middleton experienced with both her pregnancies. Its cause is unknown and the symptoms are intense: the continuous nausea and vomiting can be so violent that women can suffer from detached retinas, blown eardrums, cracked ribs and torn esophagi, according to Dr. Fejzo. The symptoms can last for several months or the entire pregnancy.
This study looked at 312 children born to 203 mothers with HG between 2007 and 2011 and compared those to 169 children born to 89 mothers who did not have HG. The disorders found included attention and sensory disorders and learning, speech and language delays. The mechanism for exposure to HG and the resulting abnormal neurologic development is not yet known, said Dr. Fejzo.
The women in the study experienced nausea and vomiting so severe that they lost at least five pounds and became so dehydrated they needed intravenous fluids. Children exposed in utero to HG have a 3.28-fold increased risk of neurodevelopmental delays.
“There is an urgent need to address whether aggressive treatment that includes vitamin and nutrient supplementation in women with early symptoms of severe nausea and vomiting decreases that risk of neurodevelopmental delay,” stressed Dr. Fejzo, noting that HG is diagnosed in 0.2 to 2% of pregnant women, although rates may be higher Asia. It accounts for more than 285,000 hospitalizations in the U.S. every year.
Previous studies have shown that HG is associated with low birth weight babies, small size for gestational age and preterm births. In earlier studies HG was associated with a 3.6-fold increased risk of behavioral or emotional disorders in adults.
Dr. Fejzo and her team are investigating the genetic basis of HG, as well as looking at risk factors and outcomes. Going forward, they hope to determine whether earlier treatment in women with symptoms limits or prevents the adverse outcomes identified in this study.
“Common antiemetic treatments were not linked to neurodevelopmental delay, but early symptoms may play a role,” wrote the investigators. “There is an urgent need to address whether aggressive treatment that includes vitamin and nutrient supplementation in women with early symptoms of severe nausea of pregnancy decreases the risk of neurodevelopmental delay.”